Active Pulmonary Sarcoidosis clinical trials

Explore recruiting active pulmonary sarcoidosis clinical trials.

Recruiting active pulmonary sarcoidosis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Active Pulmonary Sarcoidosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of a 12-week administration of OATD-01, an oral inhibitor of chitinase-1 (CHIT1), for the treatment of active pulmonary sarcoidosis (the KITE study)

Denmark, Germany, Greece, Poland, Norway, France

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of a 12-week administration of OATD-01, an oral inhibitor of chitinase-1 (CHIT1), for the treatment of active pulmonary sarcoidosis (the KITE study)

Germany, France, Greece, Denmark, Norway, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Active Pulmonary Sarcoidosis trials by city

Active Pulmonary Sarcoidosis in Toronto Active Pulmonary Sarcoidosis in Vancouver Active Pulmonary Sarcoidosis in Montreal Active Pulmonary Sarcoidosis in Calgary Active Pulmonary Sarcoidosis in Edmonton Active Pulmonary Sarcoidosis in Ottawa Active Pulmonary Sarcoidosis in Winnipeg Active Pulmonary Sarcoidosis in Quebec City Active Pulmonary Sarcoidosis in Hamilton Active Pulmonary Sarcoidosis in Kitchener Active Pulmonary Sarcoidosis in London Active Pulmonary Sarcoidosis in Halifax Active Pulmonary Sarcoidosis in New York Active Pulmonary Sarcoidosis in Los Angeles Active Pulmonary Sarcoidosis in Chicago Active Pulmonary Sarcoidosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease